Prognostic factors in anal carcinoma

Pathology

Volumn 34, Issue 6, 2002, Pages 573-578

  Fenger, Claus ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Anal squamous carcinoma; Prognostic factors

Indexed keywords

ANUS CARCINOMA; ARTICLE; CANCER STAGING; CARCINOGENESIS; CYTOGENETICS; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PATHOLOGIST; PROGNOSIS; RECTUM BIOPSY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

EID: 0036919132     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/0031302021000035956     Document Type: Article

References (64)

1. Fenger C. The anal transitional zone. Acta Path Microbiol Immunol Scand Sect A 1987; 289 (Suppl): 1-42.
2. Fenger C. Anal canal. In: Sternberg SS, editor. Histology for Pathologists. 2nd Ed. Philadelphia: Lippincott-Raven, 1997; 551-69.
3. Wendell-Smith CP. Anorectal nomenclature. Fundamental terminology. Dis Colon Rectum 2000; 43: 1349-58.
4. Federative Committee on Anatomical Terminology. Terminologia Anatomica - An International Anatomical Nomenclature. Stuttgart: Thieme, 1998.
5. Fenger C, Frisch M, Marti MC, Parc R. Tumours of the anal canal. In: Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press, 2000; 146-55.
6. Fenger C, Filipe MI. Pathology of the anal glands with special reference to their mucin histochemistry. Acta Pathol Microbiol Scand A 1977; 85: 273-85.
7. Williams GR, Talbot IC, Northover JMA, Leigh IM. Keratin expression in the normal anal canal. Histopathology 1995; 26: 39-44.
8. Williams GR, Talbot IC, Leigh IM. Keratin expression in anal carcinoma: An immunohistochemical study. Histopathology 1997; 30: 433-50.
9. Hobbs CM, Lowry MA, Owen D, Sobin LH. Anal gland carcinoma. Cancer 2001; 92: 2045-9.
10. Behrendt GC, Hansmann ML. Carcinomas of the anal canal and anal margin differ in their expression of cadherin, cytokeratins and p53. Virchows Arch 2001; 439; 782-6.
11. Zbar AP, Fenger C, Efron J, Wexner SD, Beer-Gabel M. The pathology and molecular biology of anal intraepithelial neoplasia: Comparisons with cervical and vulvar intraepithelial carcinoma. Int J Colorectal Dis 2002; 17: 203-15.
12. Frisch M. On the Etiology of Anal Squamous Carcinoma. Copenhagen: Lægeforeningens Forlag, 2002; 5-21.
13. Frisch M, Fenger C, van den Brule AJC, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999; 59: 753-7.
14. Frisch M, Biggar RJ, Goedert JJ, for the AIDS-Cancer Match Registry Study Group. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 1500-10.
15. Fairley CK, Sheil AG, McNeil JJ, et al. The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol 1994; 41: 101-5.
16. Kim JH, Sarani B, Orkin BA, et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum 2001; 44: 1496-502.
17. Efron JE, Pikarsky AJ, Gervaz P, et al. The efficacy of chemoradiation therapy in HIV seropositive patients with squamous cell carcinoma of the anus. Colorect Dis 2001; 3: 402-5.
18. Frisch M, Glimelius B, Wohlfahrt J, Adami H-O, Melbye M. Tobacco smoking as a risk factor in anal carcinoma: An antiestrogenic mechanism? J Natl Cancer Inst 1999; 91: 708-15.
19. Frisch M, Olsen JH, Bautz A, Melbye M. Benign anal lesions and the risk of anal cancer. New Engl J Med 1994; 331: 300-2.
20. Frisch M, Johansen C. Anal carcinoma in inflammatory bowel disease. Br J Cancer 2000; 83: 89-90.
21. Peiffert D, Bey P, Pernot M, et al. Conservative treatment by irradiation of epidermoid carcinomas of the anal margin. Int J Radiat Oncol Biol Phys 1997; 39: 57-66.
22. Valentini V, Mantello G, Leone MV, Luzi S, Turriziani A. Organ preservation in carcinoma of the anal canal. Rays 1997; 22: 447-53.
23. Peiffert D, Bey P, Pernot M, et al. Conservative treatment by irradiation of epidermoid cancers of the anal canal: Prognostic factors of tumoral control and complications. Int J Radiat Oncol Biol Phys 1997; 37: 313-24.
24. Friberg B, Svensson C, Goldman S, Glimelius B. The Swedish national care programme for anal carcinoma. Implementation and overall results. Acta Oncol 1998; 37: 25-32.
25. Williams GR, Talbot IC. Anal carcinoma - A histological review. Histopathology 1994; 25: 507-16.
26. Fenger C, Frisch M, Jass JJ, Williams GT, Hilden J. Anal cancer subtype reproducibility study. Virchows Arch 2000; 436: 229-33.
27. Goldman S, Auer G, Erhardt K, Seligson U. Prognostic significance of clinical stage, histologic grade, and nuclear DNA content in squamous-cell carcinoma of the anus. Dis Colon Rectum 1987; 30: 444-8.
28. Shepherd NA, Scholefield JH, Love SB, England J, Northover JMA. Prognostic factors in anal squamous carcinoma: A multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases. Histopathology 1990; 16: 545-55.
29. Grabenbauer GG, Matzel KE, Schneider IHF, et al. Sphincter preservation with chemoradiation in anal canal carcinoma. Dis Colon Rectum 1998; 41: 441-50.
30. Touboul E, Schlienger M, Buffat L, et al. Epidermoid carcinoma of the anal canal. Cancer 1994; 73: 1569-79.
31. Touboul E, Schlienger M, Buffat L, et al. Epidermoid carcinoma of the anal margin: 17 cases treated with curative-intent radiation therapy. Radiother Oncol 1995; 34: 195-202.
32. Keshtgar MRS, Amin A, Taylor I, Ell PJ. The sentinel node in anal carcinoma. Eur J Surg Oncol 2001; 27: 113-22.
33. Giovannini M, Bardou VJ, Barclay R, et al. Anal carcinoma: Prognostic value of endorectal ultrasound (ERUS). Results of a prospective multicenter study. Endoscopy 2001; 33: 231-6.
34. Tarantino D, Bernstein MA. Endoanal ultrasound in the staging and management of squamous-cell carcinoma of the anal canal. Dis Colon Rectum 2002; 45: 16-22.
35. Fenger C, Bichel P. Flow cytometric DNA analysis of anal canal epithelium and ano-rectal tumours. Acta Pathol Microbiol Scand A 1981; 89: 351-5.
36. Alvarez-Cañas MC, Fernández FA, Rodilla IG, Val-Bernal JF. Perianal basal cell carcinoma: A comparative histologic, immunohistochemical, and flow cytometric study with basaloid carcinoma of the anus. Am J Dermatopathol 1996; 18: 371-9.
37. Scott NA, Beart Jr RW, Weiland LH, Cha SS, Lieber MM. Carcinoma of the anal canal and flow cytometric DNA analysis. Br J Cancer 1989; 60: 56-8.
38. Noffsinger AE, Hui Y-Z, Suzuk L, et al. The relationship of human papillomavirus to proliferation and ploidy in carcinoma of the anus. Cancer 1995; 75: 958-67.
39. Haga T, Kim S-H, Jensen RH, Darragh T, Palefsky JM. Detection of genetic changes in anal intraepithelial neoplasia (AIN) of HIV-positive and HIV-negative men. J AIDS 2001; 26: 256-62.
40. Muleris M, Salmon RJ, Girodet J, Zafrani B, Dutrillaux B. Recurrent deletions of chromosomes 11q and 3p in anal carcinoma. Int J Cancer 1987; 39: 595-8.
41. Heselmeyer K, du Manoir S, Blegen H, et al. A recurrent pattern of chromosomal aberrations and immunophenotypic appearance defines anal squamous cell carcinomas. Br J Cancer 1997; 76: 1271-8.
42. Gervaz P, Efron J, Poza AA, et al. Loss of heterozygosity and HIV-infection in patients with anal squamous carcinoma. Dis Colon Rectum 2001; 44: 1503-8.
43. Allal AS, Alonso-Pentzke L, Remadi S. Apparent lack of prognostic value of MIB-1 index in anal carcinomas treated by radiotherapy. Br J Cancer 1998; 77: 1333-6.
44. Indinnimeo M, Cicchini C, Stazi A, et al. Immunohistochemical assessment of Ki-67 as prognostic cellular proliferation marker in anal canal carcinoma. J Exp Clin Cancer Res 2000; 19: 471-5.
45. Calore EE, Nadal SR, Manzione CR, Cavaliere MJ, de Almeida LV, Villa LL. Expression of Ki-67 can assist in predicting recurrences of low-grade anal intraepithelial neoplasia in AIDS. Dis Colon Rectum 2001; 44: 534-7.
46. Wong CS, Tsang RW, Cummings BJ, et al. Proliferation parameters in epidermoid carcinomas of the anal canal. Radiother Oncol 2000; 56: 349-53.
47. WAF1 is an indicator of malignant behaviour in anal carcinomas. Histopathology 2001; 39: 43-9.
48. Pich A, Chiusa L, Margaria E. Prognostic relevance of AgNORs in tumor pathology. Micron 2000; 31: 133-41.
49. Ogunbiyi OA, Scholefield JH, Sharp F, Ginsberg R, Rogers K. Nucleolar organiser regions (AgNORS) in anal intraepithelial neoplasia and invasive anal squamous cell carcinoma. J Clin Pathol 1992; 45: 889-93.
50. Crook T, Wrede D, Tidy J, Scholefield J, Crawford L, Vousden KH. Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus. Oncogene 1991; 6: 1251-7.
51. Jakate SM, Saclarides TJ. Immunohistochemical detection of mutant p53 protein and human papillomavirus-related E6 protein in anal cancers. Dis Colon Rectum 1993; 36: 1026-9.
52. Tanum G, Holm R. Anal carcinoma: A clinical approach to p53 and RB gene proteins. Oncol 1996; 53: 369-73.
53. Indinnimeo M, Cicchini C, Stazi A, et al. The prevalence of p53 immunoreactivity in anal canal carcinoma. Oncol Rep 1998; 5: 1455-7.
54. Wong CS, Tsao MS, Sharma V, Chapman WB, Pintilie M, Cummings BJ. Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 1999; 45: 309-14.
55. Bonin SR, Pajak TF, Russell AH, et al. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal. Cancer 1999; 85: 1226-33.
56. Indinnimeo M, Cicchini C, Stazi A, et al. Human papillomavirus infection and p53 nuclear overexpression in anal canal carcinoma. J Exp Clin Cancer Res 1999; 18: 47-52.
57. Ogunbiyi OA, Scholefield JH, Rogers K, Sharp F, Smith JHF, Polacarz SV. C-myc oncogene expression in anal squamous neoplasia. J Clin Pathol 1993; 46: 23-7.
58. Hiorns LR, Scholefield JH, Palmer JG, Shepherd NA, Kerr IB. Ki-ras oncogene mutations in non-HPV-associated anal carcinoma. J Pathol 1990; 161: 99-103.
59. Sheyn I, Noffsinger AE, Heffelfinger S, Davis B, Miller MA. Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Hum Pathol 1997; 28: 270-6.
60. Holm R, Tanum G. Evaluation of the prognostic significance of nm23/NDP kinase and cathepsin D in anal caricnomas. Virchows Arch 1996; 428: 85-9.
61. Indinnimeo M, Cicchini C, Stazi A, et al. nm23-H1 protein expression in anal canal carcinoma: Does it correlate with prognosis? J Surg Oncol 2000; 74: 163-6.
62. Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996; 32A: 2474-84.
63. Indinnimeo M, Chicchini C, Stazi A, et al. Prognostic impact of CD31 antigen expression in anal canal carcinoma. Hepato-Gastroenterol 2001; 48: 1355-8.
64. Tanum G, Hannisdal E, Stenwig B. Prognostic factors in anal carcinoma. Oncoogy 1994; 51: 22-4.